KIA
NMTR

KCM Investment Advisors’s 9 Meters Biopharma NMTR Stock Holding History

KCM Investment Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-750
Closed -$3K – 399
2022
Q3 		$3K Hold
750
– – ﹤0.01% 377
2022
Q2 		$4K Hold
750
– – ﹤0.01% 384
2022
Q1 		$9K Hold
750
– – ﹤0.01% 409
2021
Q4 		$15K Hold
750
– – ﹤0.01% 419
2021
Q3 		$20K Hold
750
– – ﹤0.01% 394
2021
Q2 		$17K Hold
750
– – ﹤0.01% 388
2021
Q1 		$18K Sell
750
-250
-25% -$7.68K ﹤0.01% 367
2020
Q4 		$17K Buy
+1,000
New +$16.7K ﹤0.01% 354

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

KCM Investment Advisors's NMTR Position: Q4 2022 in Review

KCM Investment Advisors sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 750 shares — an estimated $3K sold.

KCM Investment Advisors first reported a position in NMTR in Q4 2020 and held it in 8 quarters. The position peaked at $20K in Q3 2021. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

  • KCM Investment Advisors reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
  • KCM Investment Advisors sold 750 9 Meters Biopharma shares in Q4 2022, an estimated $3K.
  • KCM Investment Advisors first reported a position in 9 Meters Biopharma in Q4 2020 and held it in 8 quarters.
  • KCM Investment Advisors's 9 Meters Biopharma position peaked at $20K in Q3 2021.
  • 42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on KCM Investment Advisors's 13F filing for Q4 2022, filed 31 Jan 2023.